A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01
Clinical trial NCT03285308 · TERMINATED
Trial details
- NCT number
- NCT03285308
- Sponsor
- Allergan
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-29
- Primary completion
- 2020-07-08
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.